(Sharecast News) - Oxford Nanopore Technologies warned on Monday that half-year trading had missed expectations, sending shares in the biotech sharply lower, on the back of difficult conditions in China and the Middle East.
The company, which has developed nanopore-based sensing technology for use in DNA and RNA analysis, said revenues...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE